Spreadsheets, Slack messages, and files linked to an alleged group of North Korean IT workers expose their meticulous ...

On January 16, 2025, Avacta reported encouraging results from its Phase I trial of AVA6000. In patients with salivary gland ...

BioMarin's strong revenue growth, pipeline expansions, and strategic acquisitions position it for success. Read more on the ...

Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN022, an independently developed innovative bispecific antibody-drug conjugate (ADC) ...

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence ...

Amicus Therapeutics is building momentum with strong sales growth from GALAFOLD and POMBILITI/OPFOLDA. Click here to find out ...

Advances in instruments and tools, as well as focused collaborations, improve accuracy and extend the range of applications.

Affordable strategic business analyses and career consulting are now available to anyone with an internet connection.

“The days of blindly listing everywhere are over. This eBook gives hoteliers clarity and confidence to make the right choices ...

Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good morning, and welcome to the MannKind Corporation Second ...

Q2 2025 Earnings Call Transcript August 6, 2025 Novavax, Inc. beats earnings expectations. Reported EPS is $0.601, ...

Conference call today at 9:00 am ET2Q 2025 revenues of $76.5M, +6% v. 2Q 2024YTD 2025 revenues of $154.9M, +12% v. YTD ...